Trades in chemical products as its only reported business, with revenue coming entirely from this single segment. FY26 revenue from operations was Rs 493.53 lakhs, down 39.5% from Rs 816.10 lakhs in FY25, and net profit after tax was Rs 41.34 lakhs versus Rs 200.40 lakhs a year earlier. The company is listed on BSE's SME platform and operates as a small trading entity. Employee cost accounted for Rs 1.15 crore (23.3% of revenue) and other operating expenses for Rs 2.37 crore (47.9% of revenue) in FY26, with depreciation at Rs 0.54 crore (10.9%) and capex at Rs 0.43 crore (8.8%). Results were volatile across the year: Q2 FY26 swung to a net loss of Rs 431.17 lakhs on negative other income, Q3 FY26 recovered to a profit of Rs 156.26 lakhs, and Q4 FY26 ended in a net loss of Rs 325.60 lakhs. The auditor issued an unqualified opinion but flagged that some bank accounts lacked external confirmations, with management stating these were non-operational pending KYC completion. AR · MarketPing reader · 2026-08-03
Revenue streams, as the annual report describes them. Trading in Chemical products (100%). Small, single-segment chemical trading company listed on BSE's SME platform
| ₹ crore · consolidated | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Revenue | 22 | 17 | 6 | 8 | 5 |
| EBITDA (ex other income) | (6) | (2) | (4) | (2) | (2) |
| margin % | (26.6) | (13.0) | (61.4) | (29.2) | (44.8) |
| Owners' profit | (2) | 1 | 3 | 2 | 0 |
| EPS, as reported (₹) | (2.19) | 0.96 | 3.25 | 2.50 | 0.51 |
| ROE % · ROCE % | (3.0) · (3.3) | 1.3 · 2.4 | 4.2 · 6.1 | 3.1 · 4.0 | 0.6 · 0.4 |
| Debt / equity (x) | 0.00 | 0.01 | 0.00 | 0.01 | 0.01 |
| Cash from operations | (1) | 1 | (2) | (6) | 0 |
| Capex | 0 | (1) | (0) | 0 | (0) |
| ₹ crore | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 5 | 1 | 1 | 0 | 2 | 1 | 2 | 1 |
| Profit before tax | 2 | (2) | (2) | 7 | (5) | 2 | (4) | 5 |
| Net profit | 1 | (2) | (2) | 6 | (4) | 2 | (3) | 5 |
| EPS (₹) | 1.40 | (2.55) | 3.05 | 8.02 | 5.39 | 1.95 | 4.07 | 6.21 |
| Company | M.cap ₹ cr | P/E | P/B | EV/EBITDA | ROE % | ROCE % | Rev CAGR 5y % | EBITDA m. % |
|---|---|---|---|---|---|---|---|---|
| UNIPHOS ENTERPRISES LTD | 635 | 31.4 | 0.26 | — | 0.8 | 0.8 | — | — |
| VINYL CHEMICALS (I) LTD. | 402 | 17.3 | 3.09 | — | 12.7 | 16.8 | — | 9.0 |
| EVEXIA LIFECARE LIMITED | 310 | 55.0 | 0.71 | 108.2 | 0.4 | 0.3 | 0.7 | 3.3 |
| BHAVIK ENTERPRISES LIMITED | 293 | 19.8 | — | — | — | 11.1 | — | — |
| Date · filing | Category | Importance | 1-day % | 5-day % |
|---|---|---|---|---|
| 28 Aug 2026 · Newspaper publication of 33rd AGM notice filed with BSE | compliance | minimal | — | — |
| 26 Aug 2026 · Laffans Petrochemicals submits Annual Report for FY 2025-26 | results | medium | — | — |
| 26 Aug 2026 · 33rd AGM notice on Sep 22, 2026; adoption of results and auditor appointment | board shareholder meetings | low | — | — |
| 25 Aug 2026 · Board approves FY26 Board Report, 33rd AGM on Sep 22, 2026 | board shareholder meetings | low | — | — |
| 12 Aug 2026 · Newspaper publication of Q1 FY27 standalone results | compliance | minimal | — | — |
| 11 Aug 2026 · Q1 FY27 Results: PAT at Rs 497.17 lacs, EPS Rs 6.21 | results | high | — | — |
| 11 Aug 2026 · Q1 FY27 results: PAT at Rs 497 lakh, auditor flags bank accounts | results | high | — | — |
| 5 Aug 2026 · Board meeting on August 11 to consider Q1 FY27 results | board shareholder meetings | low | — | — |
| 15 Jul 2026 · RTA compliance certificate submitted for Q1 FY27 | compliance | minimal | — | — |
| 29 Jun 2026 · Trading window closure for Q1 FY27 results | compliance | minimal | — | — |
| Where a broker report shows | This document shows | Why |
|---|---|---|
| A rating (BUY / ADD / REDUCE / SELL) | A state: the latest filed quarter and the measured reactions | an event is a fact; a rating is an opinion that requires SEBI RA registration |
| A-1 LIMITED |
| 289 |
| 26.2 |
| 5.34 |
| 26.2 |
| 11.1 |
| 14.8 |
| — |
| 3.5 |
| SHANKAR LAL RAMPAL LTD | 245 | 13.3 | 2.00 | — | 11.0 | 14.7 | — | 9.4 |
| MYSORE PETRO CHEMICALS L | 93 | 17.1 | 0.41 | 100.3 | 0.4 | 0.2 | 18.0 | (0.4) |
| Yash Chemex Limited | 53 | 24.1 | 0.87 | 14.4 | 4.0 | 5.2 | 20.6 | (0.0) |
| Metric | Company | Group median | Rank | Better than |
|---|---|---|---|---|
| P/E (TTM) | 1.6 | 17.2 | 2 of 14 | 92% |
| P/B | 0.3 | 0.8 | 2 of 10 | 89% |
| ROCE | 0.3 | 3.0 | 9 of 14 | 39% |
| ROE | 0.7 | 0.8 | 6 of 10 | 44% |
| Debt / Equity | 0.0 | 0.0 | 4 of 10 | 67% |
| EBITDA margin | 476.9 | 3.3 | 1 of 9 | 100% |
| Revenue growth | 261.5 | 10.9 | 1 of 11 | 100% |
| Profit growth | (22.5) | 5.7 | 6 of 10 | 44% |
| Market cap | 22 | 93 | 9 of 13 | 33% |
| A target price and upside | The current price and the multiples against the group | a target is a forecast; a multiple is a measurement |
| Estimate years marked E | More audited years; no estimates | MarketPing publishes no forecasts — your own model lives on the Models page |
This document is a statistical summary of publicly filed information and market data, prepared by software from primary sources: SEBI results XBRL filed with BSE and NSE, LODR disclosures, shareholding patterns, exchange price data. It contains no research recommendation, no price target and no opinion on the merits of any security, and is not a research report within the meaning of the SEBI (Research Analysts) Regulations, 2014, Regulation 2(1)(w)(vii). Financial statements are as filed (consolidated where the company files consolidated results). Ratios are computed over filed lines. Where a figure is unavailable the table shows a dash rather than an estimate. The business brief is written by MarketPing's reader from the annual report and checked against it; no figure in a table was generated by a model. Nothing here constitutes investment advice, an offer or a solicitation; readers should consult a SEBI-registered adviser before acting. MarketPing is not a SEBI-registered intermediary.
